Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension

被引：52
|
作者：
Halank, M [1 ]
Miehlke, S [1 ]
Hoeffken, G [1 ]
Schmeisser, A [1 ]
Schulze, M [1 ]
Strasser, RH [1 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med, D-8027 Dresden, Germany
来源：
TRANSPLANTATION | 2004年 / 77卷 / 11期
关键词：
D O I：
10.1097/01.TP.0000122420.86904.89
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1775 / 1776
页数：2
相关论文
共 50 条
  • [31] BOSENTAN AN ORAL NONSELECTIVE ENDOTHELIN (ET) RECEPTOR ANTAGONIST, BLUNTS MONOCROTALINE-INDUCED PULMONARY-HYPERTENSION
    HILL, NS
    WARBURTON, RR
    PIETRAS, LA
    KLINGER, JR
    [J]. FASEB JOURNAL, 1995, 9 (03): : A600 - A600
  • [32] Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats
    Hill, NS
    Warburton, RR
    Pietras, L
    Klinger, JR
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1997, 83 (04) : 1209 - 1215
  • [33] Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan
    Humbert, M
    Cabane, J
    [J]. RHEUMATOLOGY, 2003, 42 (01) : 191 - 193
  • [34] Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan
    Halank, Michael
    Kolditz, Martin
    Miehlke, Stephan
    Schiemanck, Steffen
    Schmeisser, Alexander
    Hoeffken, Gert
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2005, 155 (15-16) : 376 - 380
  • [35] Successful treatment of portopulmonary hypertension with bosentan:: case report
    Staehler, G.
    von Hunnius, P.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 62 - 66
  • [36] Pharmacokinetics and safety of bosentan, an oral dual endothelin receptor antagonist in children with pulmonary arterial hypertension: BREATHE-3
    Barst, R
    Ivy, D
    Widlitz, AC
    Moore, K
    Doran, A
    Nguyen, N
    Gaitonde, MD
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 489 - 489
  • [37] Endothelin-receptor antagonist can reduce blood pressure in patients with hypertension: a meta-analysis
    Yuan, Wenming
    Cheng, Genyang
    Li, Bin
    Li, Yansheng
    Lu, Shan
    Liu, Dong
    Xiao, Jing
    Zhao, Zhanzheng
    [J]. BLOOD PRESSURE, 2017, 26 (03) : 139 - 149
  • [38] Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension
    Ghofrani, H. A.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S177 - S178
  • [39] Portopulmonary Hypertension Treated by Occlusion of a Spontaneous Portosystemic Shunt Followed by Endothelin Receptor Antagonist Administration
    Ishikawa, Tsuyoshi
    Kawamoto, Daiki
    Nishimura, Tatsuro
    Suetomi, Takeshi
    Kobayashi, Shigeki
    Takami, Taro
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (02) : 313 - 315
  • [40] Clinical pharmacology of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    [J]. CLINICAL PHARMACOKINETICS, 2004, 43 (15) : 1089 - 1115
12345